Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders
Clinical trial NCT05262517 · TERMINATED
Trial details
- NCT number
- NCT05262517
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2023-05-18
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.